Intracellular Pseudomonas aeruginosa persist and evade antibiotic treatment in a wound infection model

Stéphane Pont1, Flore Nilly1, Laurence Berry1

  • 1Laboratory of Pathogens and Host Immunity (LPHI), Université de Montpellier, CNRS, Inserm, 34095, Montpellier, France.

Plos Pathogens
|February 13, 2025
PubMed

Insights

This study reveals that persistent Pseudomonas aeruginosa bacteria hide inside zebrafish cells, evading immunity and antibiotics. Dispersing these bacterial aggregates can restore antibiotic sensitivity, offering new treatment strategies for chronic infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Zebrafish Models

Background:

  • Persistent bacterial infections pose significant challenges due to immune evasion and antibiotic resistance.
  • Pseudomonas aeruginosa is a key pathogen in chronic conditions like cystic fibrosis and non-healing wounds.

Purpose of the Study:

  • To establish a zebrafish embryo model for persistent bacterial infections.
  • To investigate the mechanisms of immune evasion and antibiotic resistance by persistent P. aeruginosa.
  • To explore novel therapeutic strategies for chronic P. aeruginosa infections.

Main Methods:

  • Utilized wounded zebrafish embryos immersed in P. aeruginosa isolates from cystic fibrosis patients.
  • Employed live and electron microscopy to visualize bacterial localization and aggregation within host cells.
  • Assessed bacterial antibiotic resistance and the efficacy of anti-biofilm molecules in vivo.

Main Results:

  • Successfully modeled persistent P. aeruginosa infection in zebrafish embryos, mimicking chronic skin infections.
  • Observed P. aeruginosa residing intracellularly within macrophages, protected from host immunity.
  • Demonstrated adaptive antibiotic resistance, with cell-permeable drugs showing higher efficiency.
  • Showed partial re-sensitization to antibiotics upon dispersion of bacterial aggregates with anti-biofilm agents.

Conclusions:

  • Intracellular localization protects persistent P. aeruginosa from host defenses and antibiotic treatment in vivo.
  • Dispersing bacterial aggregates is a promising strategy to enhance antibiotic efficacy against chronic infections.
  • The zebrafish embryo model offers high-resolution insights into persistent bacterial pathogenesis and treatment.